Common Contracts
2 similar Patent License Agreement contracts by Apimeds Pharmaceuticals US, Inc.
PATENT LICENSE AGREEMENTPatent License Agreement • September 25th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations • Delaware
This Patent License Agreement (“Agreement”), dated as of October 12, 2021 (the “Effective Date”), is by and between Kim Moon 1-lo a/k/a Chris MH Kim, MD, an individual (“Licensor”) and Apimeds Pharmaceuticals US, Inc., a Delaware corporation (“Licensee”) (each a “Party” and collectively, the “Parties”).
PATENT LICENSE AGREEMENTPatent License Agreement • June 17th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations • Delaware
This Patent License Agreement (“Agreement”), dated as of October 12, 2021 (the “Effective Date”), is by and between Kim Moon 1-lo a/k/a Chris MH Kim, MD, an individual (“Licensor”) and Apimeds Pharmaceuticals US, Inc., a Delaware corporation (“Licensee”) (each a “Party” and collectively, the “Parties”).
